Edgewise Therapeutics Inc’s recent filing unveils that its Officer JOANNE DONOVAN acquired Company’s shares for reported $0.7 million on Jan 28 ’25. In the deal valued at $27.85 per share,25,000 shares were bought.
Then, Russell Alan J sold 100,000 shares, generating $2,737,470 in total proceeds. Upon selling the shares at $27.37, the Chief Scientific Officer now owns 14,863 shares.
Before that, ALAN J RUSSELL bought 100,000 shares. Edgewise Therapeutics Inc shares valued at $2,874,000 were divested by the Director at a price of $28.74 per share.
Stifel initiated its Edgewise Therapeutics Inc [EWTX] rating to a Hold in a research note published on January 22, 2025; the price target was $30. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who began to cover the stock in late November with a ‘”an Outperform”‘ rating. Piper Sandler began covering EWTX with “an Overweight” recommendation on March 07, 2024. Truist started covering the stock on May 01, 2023. It rated EWTX as “a Buy”.
Price Performance Review of EWTX
On Tuesday, Edgewise Therapeutics Inc [NASDAQ:EWTX] saw its stock fall -0.18% to $27.80. Over the last five days, the stock has gained 1.50%. Edgewise Therapeutics Inc shares have risen nearly 4.12% since the year began. Nevertheless, the stocks have risen 76.73% over the past one year. While a 52-week high of $38.12 was reached on 01/15/25, a 52-week low of $14.90 was recorded on 01/13/25. SMA at 50 days reached $29.44, while 200 days put it at $23.64.
Levels Of Support And Resistance For EWTX Stock
The 24-hour chart illustrates a support level at 27.05, which if violated will result in even more drops to 26.30. On the upside, there is a resistance level at 28.51. A further resistance level may holdings at 29.22. The Relative Strength Index (RSI) on the 14-day chart is 49.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.23, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 34.63%. Stochastics %K at 67.91% indicates the stock is a holding.
How much short interest is there in Edgewise Therapeutics Inc?
A steep rise in short interest was recorded in Edgewise Therapeutics Inc stocks on 2025-01-15, growing by 1.09 million shares to a total of 6.74 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 5.64 million shares. There was a rise of 16.24%, which implies that there is a positive sentiment for the stock.
